Modifications of Superoxide Dismutase (SOD1) in Human Erythrocytes
Kyle C. Wilcox,Li Zhou,Joshua K. Jordon,Yi Huang,Yanbao Yu,Rachel L. Redler,Xian Chen,Michael Caplow,Nikolay V. Dokholyan
DOI: https://doi.org/10.1074/jbc.m809687200
IF: 5.485
2009-01-01
Journal of Biological Chemistry
Abstract:Over 100 mutations in Cu/Zn-superoxide dismutase (SOD1) result in familial amyotrophic lateral sclerosis. Dimer dissociation is the first step in SOD1 aggregation, and studies suggest nearly every amino acid residue in SOD1 is dynamically connected to the dimer interface. Post-translational modifications of SOD1 residues might be expected to have similar effects to mutations, but few modifications have been identified. Here we show, using SOD1 isolated from human erythrocytes, that human SOD1 is phosphorylated at threonine 2 and glutathionylated at cysteine 111. A second SOD1 phosphorylation was observed and mapped to either Thr-58 or Ser-59. Cysteine 111 glutathionylation promotes SOD1 monomer formation, a necessary initiating step in SOD1 aggregation, by causing a 2-fold increase in the Kd. This change in the dimer stability is expected to result in a 67% increase in monomer concentration, 315 nm rather than 212 nm at physiological SOD1 concentrations. Because protein glutathionylation is associated with redox regulation, our finding that glutathionylation promotes SOD1 monomer formation supports a model in which increased oxidative stress promotes SOD1 aggregation. Over 100 mutations in Cu/Zn-superoxide dismutase (SOD1) result in familial amyotrophic lateral sclerosis. Dimer dissociation is the first step in SOD1 aggregation, and studies suggest nearly every amino acid residue in SOD1 is dynamically connected to the dimer interface. Post-translational modifications of SOD1 residues might be expected to have similar effects to mutations, but few modifications have been identified. Here we show, using SOD1 isolated from human erythrocytes, that human SOD1 is phosphorylated at threonine 2 and glutathionylated at cysteine 111. A second SOD1 phosphorylation was observed and mapped to either Thr-58 or Ser-59. Cysteine 111 glutathionylation promotes SOD1 monomer formation, a necessary initiating step in SOD1 aggregation, by causing a 2-fold increase in the Kd. This change in the dimer stability is expected to result in a 67% increase in monomer concentration, 315 nm rather than 212 nm at physiological SOD1 concentrations. Because protein glutathionylation is associated with redox regulation, our finding that glutathionylation promotes SOD1 monomer formation supports a model in which increased oxidative stress promotes SOD1 aggregation. Familial amyotrophic lateral sclerosis (FALS) 4The abbreviations used are: FALS, familial amyotrophic lateral sclerosis; SOD1, Cu/Zn-superoxide dismutase; μ-ESI-FT-ICR-MS, microcapillary electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry; ECD, electron-capture dissociation; CID, collision-induced dissociation; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; LC, liquid chromatography. 4The abbreviations used are: FALS, familial amyotrophic lateral sclerosis; SOD1, Cu/Zn-superoxide dismutase; μ-ESI-FT-ICR-MS, microcapillary electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry; ECD, electron-capture dissociation; CID, collision-induced dissociation; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; LC, liquid chromatography. is the hereditary form of amyotrophic lateral sclerosis, a fatal disease characterized by progressive motor neuron loss (1Cleveland D.W. Rothstein J.D. Nat. Rev. Neurosci. 2001; 2: 806-819Crossref PubMed Scopus (1160) Google Scholar). A subset of FALS is caused by mutations in the gene encoding homodimeric Cu/Zn-superoxide dismutase (SOD1), which forms intraneuronal aggregates (2Bruijn L.I. Houseweart M.K. Kato S. Anderson K.L. Anderson S.D. Ohama E. Reaume A.G. Scott R.W. Cleveland D.W. Science. 1998; 281: 1851-1854Crossref PubMed Scopus (973) Google Scholar). Although SOD1 aggregation is involved in SOD1-mediated FALS, it is generally believed that the functional properties of the enzyme are not related to the toxic gain of function imparted by mutations in SOD1 (3Reaume A.G. Elliott J.L. Hoffman E.K. Kowall N.W. Ferrante R.J. Siwek D.F. Wilcox H.M. Flood D.G. Beal M.F. Brown Jr., R.H. Scott R.W. Snider W.D. Nat. Genet. 1996; 13: 43-47Crossref PubMed Scopus (1030) Google Scholar). However, the discovery of roles for SOD1 in the regulation of the cellular phosphorylation balance (4Juarez J.C. Manuia M. Burnett M.E. Betancourt O. Boivin B. Shaw D.E. Tonks N.K. Mazar A.P. Donate F. Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 7147-7152Crossref PubMed Scopus (193) Google Scholar) and redox state (5Harraz M.M. Marden J.J. Zhou W. Zhang Y. Williams A. Sharov V.S. Nelson K. Luo M. Paulson H. Schoneich C. Engelhardt J.F. J. Clin. Investig. 2008; 118: 659-670PubMed Google Scholar) provides additional avenues for connecting the cellular role of SOD1 to FALS. The classical studies of SOD1 were generally performed using bovine erythrocyte SOD1 or recombinant human SOD1. Although recombinant methods are widely used to produce SOD1 mutants, a disadvantage of studying recombinant SOD1 is the absence of potentially important post-translational modifications present in human tissues. The initial SOD1 crystal structure was solved using bovine erythrocyte SOD1 (6Richardson J. Thomas K.A. Rubin B.H. Richardson D.C. Proc. Natl. Acad. Sci. U. S. A. 1975; 72: 1349-1353Crossref PubMed Scopus (464) Google Scholar) and no structure of human erythrocyte SOD1 is available. Here we report results using human erythrocyte SOD1 rather than the recombinant enzyme and find that the native enzyme features a consistent pattern of post-translational modifications. Using a combination of "bottom-up" and "top-down" mass spectrometry (MS) approaches, we show that SOD1 isolated from human erythrocytes is post-translationally phosphorylated and glutathionylated. These modifications occur near the SOD1 dimer interface. Because monomer formation is thought to be the first intermediate leading to SOD1 aggregation (7Khare S.D. Caplow M. Dokholyan N.V. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 15094-15099Crossref PubMed Scopus (124) Google Scholar, 8Rakhit R. Crow J.P. Lepock J.R. Kondejewski L.H. Cashman N.R. Chakrabartty A. J. Biol. Chem. 2004; 279: 15499-15504Abstract Full Text Full Text PDF PubMed Scopus (273) Google Scholar), we tested the dimer stability of modified SOD1 found, as expected, that glutathionylation promotes the formation of SOD1 monomer. Isolation of hSOD1 from Erythrocytes—Expired human erythrocytes were obtained from the University of North Carolin-Chapel Hill Hospital blood bank. Human erythrocytes were preserved using one of several anticoagulants: AS-1, AS-3, or AS-5 (stored as long as 42 days before expiration). Bovine erythrocytes preserved with 0.38% sodium citrate were purchased from Pel-Freez Biologicals, Rogers, AR. SOD1 was isolated from human erythrocytes using a modification of the protocol originally used by McCord and Fridovich (9McCord J.M. Fridovich I. J. Biol. Chem. 1969; 244: 6049-6055Abstract Full Text PDF PubMed Google Scholar). Following acetone precipitation of SOD1, we dialyzed SOD1 against 20 mm Tris, pH 7.8, and performed hydrophobic interaction chromatography and anion exchange chromatography using an AKTA-FPLC to remove trace impurities. For hydrophobic interaction chromatography, dry (NH4)2SO4 was added to bring the final concentration to 55%. The protein was loaded onto a HiTrap phenyl-Sepharose column (GE Healthcare) and eluted with a gradient from 2 to 0 m (NH4)2SO4 in 20 mm Tris, pH 7.8. Fractions containing SOD1 were combined and dialyzed against salt-free 20 mm Tris, pH 7.8, and anion exchange chromatography was performed using a MonoQ column (GE Healthcare) with a gradient from 0 to 1 m NaCl in 20 mm Tris, pH 7.8. The fractions containing SOD1 were dialyzed against 20 mm Tris, 150 mm NaCl, pH 7.8, and concentrated. Isolation of hSOD1 from Saccharomyces cerevisiae—Human wild type SOD1 was expressed using plasmid yEP351-hwtSOD1 in the EG118 SOD1-knock out yeast strain (both kindly provided by J. S. Valentine). Growth was carried out at 30 °C for 72 h in YPD media. We uses a modified isolation protocol adapted from Goscin and Fridovich (10Goscin S.A. Fridovich I. Biochim. Biophys. Acta. 1972; 289: 276-283Crossref PubMed Scopus (68) Google Scholar) where we replaced all steps, after stirring the lysate at room temperature, with high speed centrifugation and dialysis of the supernatant against 20 mm Tris, pH 7.8, to remove the chloroform and ethanol. Trace impurities were removed by MonoQ and phenyl-Sepharose chromatography as described above. Remetallation of hSOD1 from yeast was performed by successive dialysis at 4 °C against: (a) 50 mm acetate, pH 3.5, 150 mm NaCl, 10 mm EDTA; (b) 50 mm acetate, pH 3.5, 150 mm NaCl; (c) 50 mm acetate, pH 3.5, 150 mm NaCl + CuSO4 (5-fold molar excess compared with [SOD1]); (d) 20 mm Tris, pH 7.8, 150 mm NaCl + ZnCl2 (5-fold molar excess compared with [SOD1]); and (e) 20 mm Tris, pH 7.8, 150 mm NaCl. Upon concentration with a YM-10 ultrafiltration membrane (Millipore, Bedford, MA), a blue-green coloration was observed, indicating incorporation of copper into the enzyme. Microcapillary (μ) ESI-FT-ICR-MS Analysis (Top-down Approach)—MS spectra are acquired using a hybrid Qe-Fourier Transform Ion Cyclotron Resonance (FT-ICR)-Mass Spectrometer, equipped with a 12.0-tesla actively shielded magnet (Apex Qe-FTICR-MS, 12.0 T AS, Bruker Daltonics, Billerica, MA), and an Apollo II microelectrospray source. The voltages on the μESI sprayer, interface plate, heated capillary exit, deflector, ion funnel, and skimmer were set at 4.3 kV, 3.9 kV, 300 V, 250 V, 175 V, and 80 V, respectively. The temperature of the μESI source was maintained at 180 °C. Desolvation was carried out using a nebulization gas flow (2.0 bar) and a countercurrent drying gas flow (4.0 liters/s). The electron capture dissociation (ECD) hollow dispenser cathode was heated to increase the temperature inside the ICR cell above 180 °C without application of ECD bias, eliminating non-covalent adducts. SOD1 sample solutions were directly infused using a syringe pump (Harvard Apparatus, Holliston, MA) and a 250-μl syringe (Hamilton, Reno, NV), and electrosprayed at an infusion flow rate of 90 μl/h. Before transfer, ion packets are accumulated inside the collision cell for a duration of 0.2 s. 50 MS scans per spectrum were acquired in the ICR cell with a resolution of 580,000 at m/z 400. MS/MS Fragmentation for Sequencing Full-length Proteins—FT-MS/MS spectra were obtained from collision-induced dissociation (CID) performed with in-source collision-activated dissociation followed by collision cell-activated dissociation, or from ECD. In CID experiments, argon was used as the collision gas (PAr ≈ 1.6 × 10-6 torr). Precursor ions were isolated with Q1 (Mass Selective Quadrupole) and subjected to collision cell-activated dissociation using an isolation window width of 5 Da. 50 MS/MS scans were acquired in the ICR cell with a resolution of 580,000 at m/z 400. In ECD experiments, precursor ions were isolated with Q1 and subjected to ICR cell. Isolation window width was 10 Da. Low energy electrons were generated by a heated hollow dispenser cathode with a bias voltage of -1.5 V. ECD lens voltage was set at 15.0 V. The electrons produced by the hollow cathode were pulsed into the ICR cell with a pulse length of 0.0050 s, causing fragmentation of the ions that were already trapped in the ICR cell. To maximize the ion population before irradiation, the cell was filled with 5 iterations of ion accumulation from the external collision cell of the isolated precursor as suggested (11Borchers C.H. Thapar R. Petrotchenko E.V. Torres M.P. Speir J.P. Easterling M. Dominski Z. Marzluff W.F. Proc. Natl. Acad. Sci. U. S. A. 2006; 103: 3094-3099Crossref PubMed Scopus (39) Google Scholar). In both CID and ECD experiments, 50 MS/MS scans per spectrum were acquired in the ICR cell with a resolution of 580,000 at m/z 400. Tempo LC MALDI Fractionation and MALDI-TOF-TOF Analysis (Bottom-up Approach)—SOD1 protein samples were digested with trypsin (Promega, Madison, WI) overnight at 37 °C in an enzyme to substrate ratio of 1:40 by mass. After desalting with ZipTipC18 (Millipore), 0.5 μl of the tryptic digests were directly spotted on a 384-well stainless steel matrix-assisted laser desorption/ionization (MALDI) target plate for pre-scan using a MALDI time-of-flight/time-of-flight (TOF/TOF) tandem mass spectrometer (ABI 4800 Proteomics Analyzer, Applied Biosystems, Foster City, CA). In an analytical run the peptide digests were further separated using a reverse phase liquid chromatography (LC) system (Tempo LC MALDI, Applied Biosystems, Foster City, CA). 10 μl of tryptic peptides were injected and directly loaded on a C18 capillary column (Monolithic silica RP C18 endcapped, 100 μm inner diameter, 15 cm length, Chromolith ® CapRod ®, Merck KGaA, Darmstadt, Germany) with a loading buffer (H2O/acetonitrile/trifluoroacetic acid, 98/2/0.1, v/v/v), and separated using a gradient from 100% A (H2O/acetonitrile/trifluoroacetic acid, 98/2/0.1, v/v/v) to 40% B (H2O/acetonitrile/trifluoroacetic acid, 2/98/0.1, v/v/v) over 70 min, and 40-80% B in 10 min, at a flow rate of 1.0 μl/min. The column eluates are mixed with a matrix solution of ∼7.0 mg/ml re-crystallized α-cyano-4-hydroxycinnamic acid (Sigma) in H2O/acetonitrile, 30/70 (v/v), and 5 mm ammonium citrate, deposited on a 2000-well stainless steel MALDI target plate at a frequency of 0.15 Hz, and analyzed by ABI 4800 MALDI TOF/TOF (200 Hz Nd:YAG laser, OptiBeam™). Each spot was analyzed in MS mode in the mass range of 800-4000 Da, by accumulating ion signals over 1200 laser shots. Up to 15 ions with a signal-to-noise ratio less than 30 were selected for MS/MS analysis, which was performed with a +1.0 kV collision energy and 1.0 × 10-6 torr collision gas (air) pressure. Acquisition of an MS/MS spectrum was interrupted when 2000 laser shots (40 sub-spectra from 50 laser shots each) were accumulated. Mass calibration was applied by spotting the standard peptide mixture at six places around the target plate (12Pflieger D. Junger M.A. Muller M. Rinner O. Lee H. Gehrig P.M. Gstaiger M. Aebersold R. Mol. Cell. Proteomics. 2008; 7: 326-346Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar). Acquired MS and MS/MS spectra were searched using Mascot 2.2 (Matrix Science, London, UK) embedded in GPS 3.5 (Applied Biosystems). Phosphatase Treatment of SOD1—To prepare dephosphorylated. SOD1 we use agarose-linked alkaline phosphatase (Sigma). The beads were washed using 20 mm Tris, 150 mm NaCl, pH 7.8, buffer and added to a solution of SOD1 at a 1:200 (v/v) ratio. The reaction was performed overnight at 37 °C. Size Exclusion Chromatography—Size exclusion chromatography was carried out using a Superdex 200 10/300 column (GE) and a 200-μl injection loop. The void volume of the column was ∼8 ml and a flow rate of 0.5 ml/min was used at 4 °C. For measurement of the dimer dissociation constant, Kd, samples of SOD1 at pH 7.8 were diluted to 1.25 nm to facilitate dimer dissociation using the column running buffer (20 mm Tris, pH 7.8, 150 mm NaCl, and 10 μg/liter bovine serum albumin to prevent SOD1 adherence to the column and the glass collection tubes). Samples are incubated at 37 °C for up to 5 h to ensure proper equilibration. 250-μl fractions were collected throughout the chromatography experiment for use in immunoblotting. Fractions were acetone precipitated by the addition of 4 volumes of cold acetone to the sample and a 1-h incubation at -20 °C. The samples are pelleted for 30 min at 20,000 rpm. The precipitated SOD1 was resuspended in protein solvent containing sodium dodecyl sulfate and β-mercaptoethanol and resolved by polyacrylamide gel electrophoresis. Following transfer to a polyvinylidene fluoride membrane and blocking with 5% bovine serum albumin, blots were probed with a sheep anti-SOD1 primary antibody (Calbiochem number 574597) and a rabbit anti-sheep alkaline phosphatase-conjugated secondary antibody (Thermo Scientific number 31360). The blots are incubated in ECF reagent (Amersham Biosciences) and visualized using a GE Healthcare STORM 840 Phosphor-Imager. Quantification of band intensities is performed using the ImageQuant software (GE Healthcare). Kd Determination Using SOD1 Activity—We tested for a reduction in the rate of 6-hydroxydopamine autoxidation as previously described (13Heikkila R.E. Cabbat F. Anal. Biochem. 1976; 75: 356-362Crossref PubMed Scopus (134) Google Scholar). The assay was sufficiently sensitive to allow measurement of SOD1 concentrations as low as 100 pm. The activity of glutathionylated and non-glutathionylated 2.5 nm SOD1 was measured before and after a 3-h equilibration at 37 °C. Activity assays performed after 3 and 5 h incubation at 37 °C show no additional loss in activity, indicating that the monomer-dimer equilibrium was reached at 3 h. The percent dimer dissociation at equilibrium was determined using the following equation, %Dimer dissociation=%activityloss=1−(vC−vEvC−vI)(Eq. 1) where vc is the initial rate of the control reaction, vE is the initial rate of the reaction containing equilibrated SOD1, and vI is the initial rate of the reaction measured immediately upon dilution of SOD1 from a concentrated stock solution. Assuming a physiological SOD1 concentration of 40 μm (14Kurobe N. Suzuki F. Okajima K. Kato K. Clin. Chim. Acta. 1990; 187: 11-20Crossref PubMed Scopus (53) Google Scholar), we calculated the monomer concentration based on the Kd. For a Kd of 2.25 nm, we expect the monomer concentration to be 212 nm. For a Kd of 5 nm, we expect a monomer concentration of 315 nm, a 67% increase. SOD1 Is Modified in Human Erythrocytes—Using a 12-tesla FT-ICR-MS with ultrahigh mass accuracy and resolution, full-length wild-type SOD1 from human erythrocytes was found to have a monoisotopic mass of 15837.8902 Da (Fig. 1A), corresponding to the theoretical mass of 15837.8812 Da for N-terminal acetylated wild-type human SOD1. In addition to the acetylated form, two strong peaks with masses of 15935.8702 and 16033.8462 Da corresponding to the respective addition of one (+98 Da) or two (+196 Da) hydrated phosphate groups were observed, as well as a third peak corresponding to the modification of SOD1 by glutathione (+305 Da). The protein was treated with alkaline phosphatase, which resulted in the loss of the +98 and +196 Da peaks (Fig. 1c), suggesting both sites are related to phosphorylation. To differentiate between the non-covalent association of H3PO4 or H2SO4 and a hydrated phosphate ester, both expected to result in the addition of ∼98 Da, we heated the ICR cell to above 180 °C. Heating results in the conversion of +98 and +196 Da peaks to +80 and +178 Da, respectively, but has no effect on the +305-Da shift (Fig. 1B). The CID/ECD spectra of the +80-Da peak (supplemental Fig. S1), which imply phosphorylation at threonine 2 (Thr-2) (Fig. 2B), are similar to those of the +98-Da peak (supplemental Fig. S2), indicating that the +98-Da peak belongs to single phosphorylation plus one water molecule. Similarly, the CID/ECD spectra of the +178-Da peak indicates that it possibly arises from double phosphorylation plus one water molecule (supplemental Fig. S4). A +160-Da peak corresponding to double phosphorylation was only observed in SOD1 extracted from freshly drawn human erythrocytes (supplemental Fig. S9). However, the signal intensities of the +160, +178, and +196 Da peaks were insufficient for FT-ECD fragmentation experiments in mapping the second modification site. We found that human erythrocyte SOD1 is phosphorylated at Thr-2 (Fig. 2B, supplemental Figs. S1 and S2), but due to difficulty in sequencing doubly phosphorylated SOD1, even after the enrichment of phosphorylated protein, we can only report that a second phosphorylation is possibly located at either Thr-58 or Ser-59 (supplemental Fig. S4). Residues 58 and 59 are located in the zinc loop in SOD1, which both chelates the zinc atom at the active site and accounts for several dimer interface contacts. The site of glutathionylation in human SOD1 was determined by analyzing tryptic digestions of human erythrocyte SOD1 with Tempo LC-MALDI fractionation and MALDI-TOF-TOF. The acquired MS and MS/MS spectra were searched using Mascot 2.2 embedded in GPS 3.5. In 13 unique SOD1 peptides, we found mass shifts of +305 Da from C-terminal ions y5 to y20 relative to the MS/MS spectra of the unmodified peptides (supplemental Fig. S3), which indicates that cysteine 111 (Cys-111) is susceptible to glutathionylation. Peptides containing cysteines 6, 57, and 146 were found not to be glutathionylated (supplemental Fig. S5). Human erythrocyte SOD1 was separated into multiple charge populations by anion exchange chromatography (Fig. 1D). Each population shows distinct modification patterns in its mass spectrum (Fig. 1E). The SOD1 that elutes at the highest ionic strength, population 3 (Fig. 1, D and E), has a dominant peak at m/z = 16142.9600 Da, corresponding to the acetylated protein derivatized with glutathione. The extent of phosphorylation varies in SOD1 populations 1 and 2 that elute at low and medium salt concentrations (Fig. 1, D and E). A pool of SOD1 that is simultaneously phosphorylated and glutathionylated was also observed (Fig. 1E). Distribution of Modifications in Individual Erythrocyte Samples—The modifications described above were observed in SOD1 isolated from erythrocytes pooled from multiple donors and as such, any modifications could have arisen due primarily to contributions from a single donor. To investigate the consistency of glutathionylation and phosphorylation levels between individuals, we next compared SOD1 from individual samples of human erythrocytes. Of six individual samples, five contained both phosphorylation and glutathionylation (Table 1). One sample lacked glutathione but was significantly phosphorylated. Assuming independent probabilities of phosphorylation and glutathionylation of SOD1, we expect the probability of observing both modifications to be the product of the individual frequencies. In erythrocyte samples 1-3, the calculated frequency of combined phosphorylation and glutathionylation is significantly smaller than the measured frequency, suggesting that phosphorylation and glutathionylation are co-dependent in the case of SOD1. However, the observed frequency of combined modification in samples 4 and 5 is only marginally higher than the expected frequency and is within the experimental error. This behavior may arise from differences in phosphatase activity among individuals, or other variables not controlled for in this study.TABLE 1Comparison of modifications in independent erythrocyte samplesSample No.Unmodified SOD1Phosphorylated SOD1Glutathionylated SOD1Both151.1 ± 11%8.5 ± 1.8% fP = 0.30 ± 0.0518.8 ± 3.9% fG = 0.41 ± 0.0621.7 ± 4.6% Expected = 12 ± 4%236.9 ± 2.9%6.6 ± 1.3% fP = 0.29 ± 0.0134.0 ± 3.6% fG = 0.57 ± 0.0522.6 ± 0.3% Expected = 16.5 ± 1.6%341.1 ± 5.0%14.4 ± 4.4% fP = 0.33 ± 0.0525.8 ± 1.5% fG = 0.45 ± 0.0218.7 ± 1.6% Expected = 14.7 ± 2.3%453.6 ± 0.7%22.5 ± 4% fP = 0.35 ± 0.0417.1 ± 3.6% fG = 0.29 ± 0.0412.2 ± 1.0% Expected = 10.2 ± 1.8%545.2 ± 3.0%14.6 ± 0.5% fP = 0.27 ± 0.0131.5 ± 3.1% fG = 0.44 ± 0.0312.0 ± 0.3% Expected = 11.6 ± 0.9%654.4 ± 11.4%45.6 ± 9.6%NoneNone Open table in a new tab Modifications in Freshly Drawn Human Erythrocytes—The phosphorylation and glutathionylation of human erythrocyte SOD1 does not occur as a result of long-term blood storage. We isolated SOD1 from human erythrocytes immediately following their collection from two donors. The results are summarized in Table 2. Mass spectra from each donor (ages 37 and 73 years) included major peaks related to both SOD1 phosphorylation and glutathionylation. In addition, we observed peaks related to oxidized SOD1. These peaks were shifted +16 and +32 Da from the unmodified mass of SOD1 (supplemental Fig. S9). Because there are no +16 or +32 Da shifted peaks relative to either phosphorylated or glutathionylated SOD1, we postulate that Cys-111 is the site of the oxidation, as has been observed in vitro (15Fujiwara N. Nakano M. Kato S. Yoshihara D. Ookawara T. Eguchi H. Taniguchi N. Suzuki K. J. Biol. Chem. 2007; 282: 35933-35944Abstract Full Text Full Text PDF PubMed Scopus (107) Google Scholar). Alternatively, histidine residues in SOD1 might be oxidized because SOD1 lacks methionine and the oxidation of histidine residues in SOD1 has been observed previously (16Rakhit R. Cunningham P. Furtos-Matei A. Dahan S. Qi X.F. Crow J.P. Cashman N.R. Kondejewski L.H. Chakrabartty A. J. Biol. Chem. 2002; 277: 47551-47556Abstract Full Text Full Text PDF PubMed Scopus (265) Google Scholar). It is interesting to note the abundance of oxidized SOD1 species in sample B compared with sample A given that the more highly oxidized sample was drawn from a 73-year-old donor, whereas sample A was drawn from a 37-year-old donor. However, a comparison based on only two samples is insufficient to support a hypothesis that the difference is related to age.TABLE 2Comparison of modifications in freshly drawn single erythrocyte samplesSample I.D.Unmodified SOD1Phosphorylated SOD1Glutathionylated SOD1BothA: age 3738.6 ± 5.8%13.3 ± 2.0% fP = 0.23 ± 0.0338 ± 5.7% fG = 0.48 ± 0.0610.1 ± 1.5% Expected = 11.3 ± 2.0%B: age 7337.4 ± 5.6%8.4 ± 1.3% fP = 0.22 ± 0.0240.8 ± 6.1% fG = 0.54 ± 0.0613.4 ± 2.0% Expected = 11.% ± 1.7% Open table in a new tab Species/System Effects on Modifications—Because S. cerevisiae contain a copper chaperone for SOD1, it is widely used for expressing recombinant human SOD1, but do phosphorylation and glutathionylation of human SOD1 occur in yeast or other systems used to isolate SOD1? To answer this question, we purified and analyzed recombinant SOD1 from yeast, as well as endogenous SOD1 from both yeast and bovine erythrocytes. Mass spectra of human SOD1 isolated from S. cerevisiae indicate an exact match with the acetylated, unmodified SOD1 found in human erythrocytes (supplemental Fig. S8). We separated a sample of yeast-expressed human SOD1 into subpopulations of high and low negative net charge and found similar mass shifts in the deconvoluted mass spectra indicating SOD1 glutathionylation but not phosphorylation (supplemental Fig. S8). The mass spectrum of SOD1 isolated from bovine erythrocytes using the identical protocol used for human erythrocytes indicates bovine SOD is neither phosphorylated nor glutathionylated, nor is endogenous yeast SOD1 (supplemental Figs. S6 and S7, respectively), an expected result given that neither species has a cysteine at position 111 in SOD1. Cysteine 6 is conserved between bovine and human SOD1 but we find no glutathionylation of this residue in either species. We hypothesize that SOD1 phosphorylation was not previously observed due to the common use of bovine erythrocyte SOD1 or recombinant human SOD1. Effect of Modifications on SOD1 Dimer Dissociation—Thr-2 appears to be at a sufficient distance so as not to participate directly in the SOD1 dimer interface. However, phosphorylation can change both the structure and dynamics of proteins (17Baker J.M. Hudson R.P. Kanelis V. Choy W.Y. Thibodeau P.H. Thomas P.J. Forman-Kay J.D. Nat. Struct. Mol. Biol. 2007; 14: 738-745Crossref PubMed Scopus (222) Google Scholar) and thus, the distance from the interface and the active site does not preclude Thr-2 phosphorylation from altering the stability or activity of SOD1. Cys-111 residues in each SOD1 monomer are directly apposed in a cleft at the dimer interface. We postulated that the addition of the glutathione tripeptide to Cys-111 will result in a measurable decrease in SOD1 dimer stability. Because of the proximity of both Thr-2 phosphorylation and Cys-111 glutathionylation to the dimer interface and evidence that dimer stability is important for preventing SOD1 aggregation (18Ray S.S. Nowak R.J. Strokovich K. Brown Jr., R.H. Walz T. Lansbury Jr., P.T. Biochemistry. 2004; 43: 4899-4905Crossref PubMed Scopus (100) Google Scholar, 19Ray S.S. Nowak R.J. Brown Jr., R.H. Lansbury Jr., P.T. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 3639-3644Crossref PubMed Scopus (118) Google Scholar), we measured the effect of glutathionylation and phosphorylation on the in vitro stability of dimeric SOD1. Using size exclusion chromatography, we compared SOD1 species separated by anion exchange as described above (peaks 1 and 3 in Fig. 1E). Altered dimer stability of SOD1 in peak 3 relative to peak 1 is expected to be the result of Cys-111 glutathionylation because substoichiometric amounts of phosphorylation are present in both SOD1 species. Due to the unusually high stability of the SOD1 dimer (the dissociation constant of human SOD1 isolated from yeast is less than 10 nm (20Doucette P.A. Whitson L.J. Cao X. Schirf V. Demeler B. Valentine J.S. Hansen J.C. Hart P.J. J. Biol. Chem. 2004; 279: 54558-54566Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar)), it was necessary to perform the experiment at low concentrations. To observe dissociation into monomers, we performed size exclusion chromatography using 1.25 nm SOD1. We compared SOD1 with and without glutathionylation and found that glutathionylation has a marked destabilizing effect on the SOD1 dimer. Progressive SOD1 dimer dissociation was observed upon incubation at 37 °C for up to 5 h. We observed a 3-fold increase in monomer formation in glutathionylated SOD1 relative to SOD1 unmodified by glutathione (Fig. 3). Kd Determination Using an Assay for SOD1 Activity—Monomeric SOD1 was postulated to have reduced activity based on findings that mutations forcing monomeric SOD1 show an 80% activity loss (21Ferraroni M. Rypniewski W. Wilson K.S. Viezzoli M.S. Banci L. Bertini